- Home
- IDXX
as 07-26-2024 4:00pm EST
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | WESTBROOK |
| Market Cap: | 39.9B | IPO Year: | 1991 |
| Target Price: | $583.00 | AVG Volume (30 days): | 495.7K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.32 | EPS Growth: | 24.04 |
| 52 Week Low/High: | $372.50 - $583.39 | Next Earning Date: | 08-06-2024 |
| Revenue: | $3,724,853,000 | Revenue Growth: | 8.57% |
| Revenue Growth (this year): | 9.78% | Revenue Growth (next year): | 9.95% |
Stock Insider Trading Activity of IDEXX Laboratories Inc. (IDXX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Claflin Bruce L. | IDXX | Director | May 17 '24 | Sell | $540.80 | 200 | $108,160.00 | 161 | SEC Form 4 |
| Vandebroek Sophie V. | IDXX | Director | Mar 5 '24 | Sell | $562.98 | 1,404 | $790,427.01 | 1,216 | SEC Form 4 |
Latest IDEXX Laboratories Inc. News
IDXX Breaking Stock News: Dive into IDXX Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
BTIG Starts IDEXX Laboratories With Buy Rating, $580 Price Target
Argus Research
3 days ago
IDXX: Lowering target price to $494.00
Zacks
4 days ago
Strong CAG Sales to Aid IDEXX Laboratories' (IDXX) Q2 Earnings
Argus Research
10 days ago
IDXX: Raising target price to $524.00
MT Newswires
10 days ago
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating
Simply Wall St.
12 days ago
Shareholders Are Optimistic That IDEXX Laboratories (NASDAQ:IDXX) Will Multiply In Value
Zacks
15 days ago
TMO or IDXX: Which Is the Better Value Stock Right Now?
Argus Research
17 days ago
IDXX: Raising target price to $502.00
Compare IDXX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IDXX IDEXX Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.